| Serial Number | 97130395 |
| Word Mark | CUROGEN |
| Filing Date | Wednesday, November 17, 2021 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Wednesday, September 11, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 28, 2023 |
| Goods and Services | pharmaceutical preparations for diagnosis; diagnostic agents for pharmaceutical use; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of auto-immune diseases; monoclonal antibodies for medical purposes; polyclonal antibodies for medical purposes; compounds for treating cancer; biological preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; chemical preparations for pharmaceutical purposes for the treatment of cancer or autoimmune diseases; immunoassay reagents for medical use; biological preparations for medical purposes for the treatment of cancer or autoimmune diseases; chemico-pharmaceutical preparations for the treatment of cancer or autoimmune diseases; preparations of microorganisms for medical purposes; pharmaceuticals for the treatment of cancer or autoimmune diseases; pharmaceutical compositions for the treatment of cancer or autoimmune diseases |
| Goods and Services | pharmaceutical drug development services; research on the subject of pharmaceuticals; pharmaceutical drug development services; medicine research; analysis and evaluation of medical product development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information on medical research being testing, inspection, and research of medical products; evaluating of clinical trial progress; development of biologics; research of biologics; biological research and analysis; drug discovery services; conducting clinical trials for others; scientific research; clinical trials; biological laboratory services; laboratory research in the field of chemistry; laboratory analysis in the field of chemistry; research and development of new products for others; pharmaceutical research and development |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 23, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 23, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CUROGEN Technology Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Gyeonggi-do 16419 KR |
| Party Name | CUROGEN Technology Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Gyeonggi-do 16419 KR |
| Event Date | Event Description |
| Saturday, November 20, 2021 | NEW APPLICATION ENTERED |
| Tuesday, November 23, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, August 29, 2022 | ASSIGNED TO EXAMINER |
| Monday, August 29, 2022 | NON-FINAL ACTION WRITTEN |
| Monday, August 29, 2022 | NON-FINAL ACTION E-MAILED |
| Monday, August 29, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, January 12, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, January 12, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, January 12, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, January 17, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, January 31, 2023 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Wednesday, April 26, 2023 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Wednesday, March 8, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 28, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 28, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Sunday, August 6, 2023 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Tuesday, September 19, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, March 6, 2024 | SOU EXTENSION 1 GRANTED |
| Wednesday, March 6, 2024 | SOU EXTENSION 1 FILED |
| Wednesday, March 6, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, March 7, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, September 11, 2024 | TEAS PETITION TO AMEND BASIS RECEIVED |
| Wednesday, September 11, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, September 11, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, September 11, 2024 | SOU EXTENSION 2 GRANTED |
| Wednesday, September 11, 2024 | SOU EXTENSION 2 FILED |